featured
Glucose-Lowering Therapies Prescription and COVID-19 Mortality in People With T2D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prescription of Glucose-Lowering Therapies and Risk of COVID-19 Mortality in People With Type 2 Diabetes: A Nationwide Observational Study in England
Lancet Diabetes Endocrinol 2021 Mar 30;[EPub Ahead of Print], K Khunti, P Knighton, F Zaccardi, C Bakhai, E Barron, N Holman, P Kar, C Meace, N Sattar, S Sharp, NJ Wareham, A Weaver, E Woch, B Young, J ValabhjiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.